<DOC>
	<DOCNO>NCT01050868</DOCNO>
	<brief_summary>This prospective , non-randomized , non-controlled , interventional study determine whether Roche automate bolus caclulator ( ABC ) reduce post-meal hyperglycemia well competitor 's ABC without cause significant hypoglycemia .</brief_summary>
	<brief_title>Comparison Management Post-prandial Hyperglycemia Multiple Bolus Calculators</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Subjects &gt; /= 18 year screen Type 1 diabetic currently use insulin pump management diabetes pump least least 6 month prior screen visit Subjects use fast act analog insulin HbA1c = 9 % ( measure DCA 2000 ) Willing perform period intensive blood glucose ( BG ) monitor 21 day prior study ( ~10 test per day ) skip meal testmeals Willing use 3 different bolus calculator course study Willing undergo plan hyperglycemia Willing perform high frequency BG monitoring ( &gt; 20 / day ) experiment Type 2 Diabetes Manifest severe late complication diabetes ( e.g . severe macro microangiopathy , severe neuropathy , severe retinopathy and/or severe nephropathy ) Current addiction alcohol substance abuse Pregnant lactate woman Any known lifethreatening disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>